Malaria vaccine shows promise: study

An experimental malaria vaccine tested on children in Burkina Faso has shown "a high level of efficacy" in protecting against the disease, a study published in the United States said Wednesday.

The study was initially planned to study the safety and of the vaccine, known by the name MSP3.

"However, as attacks were documented as part of the safety follow-up, the investigators decided to explore the protective effect of the vaccine," said report appearing in Thursday's .

"Results indicate a high level of efficacy."

In the study, 45 children aged 12-24 months were randomized into three groups receiving doses of either 15 or 30 micrograms of the experimental malaria vaccine, or the control vaccine against .

"Comparing the groups, they found a striking difference," the study said.

It found children who received the new vaccine at either dose had incidence rates three to four times lower than children who did not, "yielding efficacy rates of 64 and 77 percent protection against clinical malaria," the journal article said.

"I found the results of this preliminary study in Burkina Faso to be most encouraging," said Louis Miller, former chief of the Malaria Vaccine Development Branch of the US National Institutes of Health, in the journal.

"Larger efficacy trials in diverse epidemiological settings will be required to confirm these results."

The study was led by scientists from the National Center for Research and Training on Malaria in Burkina Faso, the London School of Tropical Medicine and Hygiene and the Paris-based Pasteur Institute.

The researchers found those receiving the vaccine at either dose had more antibodies protecting against malaria.

"Despite the limitations of the design and small sample size, these results strongly suggest a significant protective effect over the follow-up period," the study said.

Malaria claimed 781,000 lives in 2009, according to the UN's World Health Organization (WHO). About 90 percent of malaria deaths each year occur in Africa and 92 percent of those are children aged under five.

Scientists say fighting the disease is complicated because the parasite, Plasmodium falciparum, is several hundred times larger than viruses like measles or polio, but is also as variable as viruses like influenza and HIV.

"In addition to demonstrating safety, the vaccine induced the desired type of immune responses in all vaccinated children: those associated with natural protection observed in adults," the study concluded.

"This provides hope that the above approach may provide an artificial way to shortcut the 10-20 years of malaria exposure needed to acquire that highly desirable immune state seen in adults."

The only in advanced clinical trials is the RTS,S vaccine being developed by British drugmaker GlaxoSmithKline, which could become available in 2015. A 2008 study showed the RTS,S vaccine with an efficacy of 53 percent for young children and 65 percent for infants.

add to favorites email to friend print save as pdf

Related Stories

New malaria drug works in infants

Oct 19, 2007

Scientists say a new malaria vaccine being tested in Mozambique was successful in protecting infants less than 1 year old.

Early promising results in malaria vaccine trial in Mali

Jan 23, 2008

A small clinical trial conducted by an international team of researchers in Mali has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it.

Recommended for you

Africa's uneven health care becomes easy prey for Ebola

2 hours ago

The disparity in African countries' ability to fight Ebola has left the continent fighting an uneven struggle against a disease that doesn't respect borders—yet relatively simple measures could help, experts say.

Ebola case stokes concerns for Liberians in Texas

3 hours ago

The first case of Ebola diagnosed in the U.S. has been confirmed in a man who recently traveled from Liberia to Dallas, sending chills through the area's West African community whose leaders urged caution ...

Is Australia prepared for Ebola?

6 hours ago

Australia needs to be proactive about potential disease outbreaks like Ebola and establish a national centre for disease control.

Dallas hospital confirms first Ebola case in US

12 hours ago

A patient at a Dallas hospital has tested positive for Ebola, the first case of the disease to be diagnosed in the United States, federal health officials announced Tuesday.

User comments